新型轮廓神经血管系统在MRI和频谱CT治疗颅内动脉瘤中的可能随访方案

ESMINT 2021 – Abstract book Pub Date : 2021-08-01 DOI:10.1136/neurintsurg-2021-esmint.11

J. Madjidyar, J. Hensler, Olav Jansen, F. Wodarg

{"title":"新型轮廓神经血管系统在MRI和频谱CT治疗颅内动脉瘤中的可能随访方案","authors":"J. Madjidyar, J. Hensler, Olav Jansen, F. Wodarg","doi":"10.1136/neurintsurg-2021-esmint.11","DOIUrl":null,"url":null,"abstract":"was achieved in 87.5%(7/8). There was one delayed death at 2-year from an unrelated cause. Conclusions pCONUS 2 and pCONUS 2-HPC have good medium-term safety profiles with no procedure-related mortality and acceptable morbidity. Good occlusion rates was noted at 6-months (85.7%) and 2 years (87.5%).","PeriodicalId":341667,"journal":{"name":"ESMINT 2021 – Abstract book","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EP11 A possible follow-up protocol for the novel contour neurovascular system for intracranial aneurysm treatment in MRI and spectral CT\",\"authors\":\"J. Madjidyar, J. Hensler, Olav Jansen, F. Wodarg\",\"doi\":\"10.1136/neurintsurg-2021-esmint.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"was achieved in 87.5%(7/8). There was one delayed death at 2-year from an unrelated cause. Conclusions pCONUS 2 and pCONUS 2-HPC have good medium-term safety profiles with no procedure-related mortality and acceptable morbidity. Good occlusion rates was noted at 6-months (85.7%) and 2 years (87.5%).\",\"PeriodicalId\":341667,\"journal\":{\"name\":\"ESMINT 2021 – Abstract book\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESMINT 2021 – Abstract book\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/neurintsurg-2021-esmint.11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMINT 2021 – Abstract book","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/neurintsurg-2021-esmint.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

达到87.5%(7/8)。有一例两岁时因无关原因延迟死亡。结论pCONUS 2和pCONUS 2- hpc具有良好的中期安全性，无手术相关死亡率和可接受的发病率。6个月(85.7%)和2年(87.5%)牙合良好。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

EP11 A possible follow-up protocol for the novel contour neurovascular system for intracranial aneurysm treatment in MRI and spectral CT

was achieved in 87.5%(7/8). There was one delayed death at 2-year from an unrelated cause. Conclusions pCONUS 2 and pCONUS 2-HPC have good medium-term safety profiles with no procedure-related mortality and acceptable morbidity. Good occlusion rates was noted at 6-months (85.7%) and 2 years (87.5%).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ESMINT 2021 – Abstract book

自引率

0.00%

发文量